Meridian Bioscience Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Meridian Bioscience are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Meridian Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Meridian Bioscience is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 49.8 M | |
| Total Cashflows From Investing Activities | -11.1 M |
Meridian |
Meridian Bioscience Relative Risk vs. Return Landscape
If you would invest (100.00) in Meridian Bioscience on November 1, 2025 and sell it today you would earn a total of 100.00 from holding Meridian Bioscience or generate -100.0% return on investment over 90 days. Meridian Bioscience is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Meridian, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Meridian Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Meridian Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Meridian Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Meridian Bioscience is not yet fully synchronised with the market data | |
| Meridian Bioscience has some characteristics of a very speculative penny stock | |
| Meridian Bioscience has a very high chance of going through financial distress in the upcoming years | |
| Over 91.0% of the company outstanding shares are owned by institutional investors |
Meridian Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Meridian Stock often depends not only on the future outlook of the current and potential Meridian Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Meridian Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44 M | |
| Cash And Short Term Investments | 81.5 M |
Meridian Bioscience Fundamentals Growth
Meridian Stock prices reflect investors' perceptions of the future prospects and financial health of Meridian Bioscience, and Meridian Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Meridian Stock performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 1.39 B | |||
| Shares Outstanding | 43.83 M | |||
| Price To Earning | 19.81 X | |||
| Price To Book | 3.92 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 333.02 M | |||
| EBITDA | 72.02 M | |||
| Cash And Equivalents | 83.49 M | |||
| Cash Per Share | 1.91 X | |||
| Total Debt | 25 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 8.41 X | |||
| Cash Flow From Operations | 82.36 M | |||
| Earnings Per Share | 0.96 X | |||
| Total Asset | 463.1 M | |||
| Retained Earnings | 36.09 M | |||
| Current Asset | 126.79 M | |||
| Current Liabilities | 22.57 M | |||
Things to note about Meridian Bioscience performance evaluation
Checking the ongoing alerts about Meridian Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Meridian Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Meridian Bioscience is not yet fully synchronised with the market data | |
| Meridian Bioscience has some characteristics of a very speculative penny stock | |
| Meridian Bioscience has a very high chance of going through financial distress in the upcoming years | |
| Over 91.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Meridian Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Meridian Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Meridian Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Meridian Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Meridian Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Meridian Bioscience's stock. These opinions can provide insight into Meridian Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |